世界のBRAFキナーゼ阻害剤産業:成長傾向・競合分析

QYResearchが発行した調査報告書(DATA909X00353)
◆英語タイトル:Global BRAF Kinase Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード:DATA909X00353
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月22日
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥627,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥940,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,254,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・BRAFキナーゼ阻害剤の種類別市場規模:ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ
・BRAFキナーゼ阻害剤の用途別市場規模:病院、医学研究所、クリニック、その他
・BRAFキナーゼ阻害剤の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Array BioPharma Inc.、Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period.
In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for BRAF Kinase Inhibitors.

This study researches the market size of BRAF Kinase Inhibitors, presents the global BRAF Kinase Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of BRAF Kinase Inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of BRAF Kinase Inhibitors for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG

Market Segment by Product Type
Dabrafenib
Sorafenib
Vemurafenib
Encorafenib

Market Segment by Application
Hospital
Medical Research Institute
Clinic
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global BRAF Kinase Inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key BRAF Kinase Inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of BRAF Kinase Inhibitors are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Type
1.3.2 Dabrafenib
1.3.3 Sorafenib
1.3.4 Vemurafenib
1.3.5 Encorafenib
1.4 Market Segment by Application
1.4.1 Global BRAF Kinase Inhibitors Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Medical Research Institute
1.4.4 Clinic
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global BRAF Kinase Inhibitors Market Size
2.1.1 Global BRAF Kinase Inhibitors Revenue 2014-2025
2.1.2 Global BRAF Kinase Inhibitors Sales 2014-2025
2.2 BRAF Kinase Inhibitors Growth Rate by Regions
2.2.1 Global BRAF Kinase Inhibitors Sales by Regions 2014-2019
2.2.2 Global BRAF Kinase Inhibitors Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 BRAF Kinase Inhibitors Sales by Manufacturers
3.1.1 BRAF Kinase Inhibitors Sales by Manufacturers 2014-2019
3.1.2 BRAF Kinase Inhibitors Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 BRAF Kinase Inhibitors Revenue by Manufacturers (2014-2019)
3.2.2 BRAF Kinase Inhibitors Revenue Share by Manufacturers (2014-2019)
3.2.3 Global BRAF Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 BRAF Kinase Inhibitors Price by Manufacturers
3.4 Key Manufacturers BRAF Kinase Inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market
3.6 Key Manufacturers BRAF Kinase Inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Dabrafenib Sales and Revenue (2014-2019)
4.1.2 Sorafenib Sales and Revenue (2014-2019)
4.1.3 Vemurafenib Sales and Revenue (2014-2019)
4.1.4 Encorafenib Sales and Revenue (2014-2019)
4.2 Global BRAF Kinase Inhibitors Sales Market Share by Type
4.3 Global BRAF Kinase Inhibitors Revenue Market Share by Type
4.4 BRAF Kinase Inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global BRAF Kinase Inhibitors Sales by Application

6 North America
6.1 North America BRAF Kinase Inhibitors Breakdown Data by Company
6.2 North America BRAF Kinase Inhibitors Breakdown Data by Type
6.3 North America BRAF Kinase Inhibitors Breakdown Data by Application
6.4 North America BRAF Kinase Inhibitors Breakdown Data by Countries
6.4.1 North America BRAF Kinase Inhibitors Sales by Countries
6.4.2 North America BRAF Kinase Inhibitors Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe BRAF Kinase Inhibitors Breakdown Data by Company
7.2 Europe BRAF Kinase Inhibitors Breakdown Data by Type
7.3 Europe BRAF Kinase Inhibitors Breakdown Data by Application
7.4 Europe BRAF Kinase Inhibitors Breakdown Data by Countries
7.4.1 Europe BRAF Kinase Inhibitors Sales by Countries
7.4.2 Europe BRAF Kinase Inhibitors Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Company
8.2 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Type
8.3 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Application
8.4 Asia Pacific BRAF Kinase Inhibitors Breakdown Data by Regions
8.4.1 Asia Pacific BRAF Kinase Inhibitors Sales by Countries
8.4.2 Asia Pacific BRAF Kinase Inhibitors Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America BRAF Kinase Inhibitors Breakdown Data by Company
9.2 Central & South America BRAF Kinase Inhibitors Breakdown Data by Type
9.3 Central & South America BRAF Kinase Inhibitors Breakdown Data by Application
9.4 Central & South America BRAF Kinase Inhibitors Breakdown Data by Countries
9.4.1 Central & South America BRAF Kinase Inhibitors Sales by Countries
9.4.2 Central & South America BRAF Kinase Inhibitors Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Type
10.2 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Application
10.3 Middle East and Africa BRAF Kinase Inhibitors Breakdown Data by Countries
10.3.1 Middle East and Africa BRAF Kinase Inhibitors Sales by Countries
10.3.2 Middle East and Africa BRAF Kinase Inhibitors Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Array BioPharma Inc.
11.1.1 Array BioPharma Inc. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.1.4 BRAF Kinase Inhibitors Product Introduction
11.1.5 Array BioPharma Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.2.4 BRAF Kinase Inhibitors Product Introduction
11.2.5 Bayer AG Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.3.4 BRAF Kinase Inhibitors Product Introduction
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of BRAF Kinase Inhibitors
11.4.4 BRAF Kinase Inhibitors Product Introduction
11.4.5 Novartis AG Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 BRAF Kinase Inhibitors Sales Channels
12.2.2 BRAF Kinase Inhibitors Distributors
12.3 BRAF Kinase Inhibitors Customers

13 Market Forecast
13.1 Global BRAF Kinase Inhibitors Sales and Revenue Forecast 2019-2025
13.2 Global BRAF Kinase Inhibitors Sales Forecast by Type
13.3 Global BRAF Kinase Inhibitors Sales Forecast by Application
13.4 BRAF Kinase Inhibitors Forecast by Regions
13.4.1 Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025
13.4.2 Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America BRAF Kinase Inhibitors Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe BRAF Kinase Inhibitors Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure BRAF Kinase Inhibitors Product Picture
Table BRAF Kinase Inhibitors Key Market Segments
Table Major Manufacturers BRAF Kinase Inhibitors Covered in This Report
Table Global BRAF Kinase Inhibitors Market Size Growth Rate by Type 2019-2025 (K Liter) & (Million US$)
Figure Global BRAF Kinase Inhibitors Sales Market Shar by Type 2014-2025
Figure Dabrafenib Figures
Table Major Manufacturers of Dabrafenib
Figure Sorafenib Figures
Table Major Manufacturers of Sorafenib
Figure Vemurafenib Figures
Table Major Manufacturers of Vemurafenib
Figure Encorafenib Figures
Table Major Manufacturers of Encorafenib
Table Global BRAF Kinase Inhibitors Market Share by Application 2019-2025 (K Liter)
Figure Hospital Use Case
Figure Medical Research Institute Use Case
Figure Clinic Use Case
Figure Other Use Case
Figure BRAF Kinase Inhibitors Report Years Considered
Figure Global BRAF Kinase Inhibitors Market Size 2014-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Sales 2014-2019 (K Liter)
Table Global BRAF Kinase Inhibitors Market Size by Regions 2014-2019 (K Liter) & (Million US$)
Table Global BRAF Kinase Inhibitors Sales by Regions 2014-2019 (K Liter)
Table Global BRAF Kinase Inhibitors Sales Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Sales Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Global BRAF Kinase Inhibitors Revenue by Regions 2014-2019 (Million US$)
Table Global BRAF Kinase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global BRAF Kinase Inhibitors Sales by Manufacturers (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Manufacturers (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Share by Manufacturers in 2018
Table BRAF Kinase Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
Table BRAF Kinase Inhibitors Revenue Share by Manufacturers (2014-2019)
Figure BRAF Kinase Inhibitors Value Share by Manufacturers in 2018
Table Global BRAF Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers BRAF Kinase Inhibitors Price (2014-2019) (USD/Liter)
Table Key Manufacturers BRAF Kinase Inhibitors Plants/Factories Distribution
Table Key Manufacturers BRAF Kinase Inhibitors Area Served
Table Date of Key Manufacturers Enter into BRAF Kinase Inhibitors Market
Table Key Manufacturers BRAF Kinase Inhibitors Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Dabrafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Sorafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Vemurafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global Encorafenib Sales an目录输出!D Revenue (2014-2019) (K Liter) & (Million US$)
Table Global BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Global BRAF Kinase Inhibitors Revenue by Type (2014-2019) (Million US$)
Table Global BRAF Kinase Inhibitors Revenue Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Type (2014-2019)
Figure Global BRAF Kinase Inhibitors Revenue Market Share by Type in 2018
Table BRAF Kinase Inhibitors Price by Type 2014-2019 (USD/Liter)
Table Global BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Global BRAF Kinase Inhibitors Sales Share by Application (2014-2019)
Figure Global Sales BRAF Kinase Inhibitors Market Share by Application (2014-2019)
Figure Global Sales BRAF Kinase Inhibitors Market Share by Application in 2018
Figure North America BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure North America BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table North America BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure North America BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table North America BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure North America BRAF Kinase Inhibitors Market Share by Type in 2018
Table North America BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure North America BRAF Kinase Inhibitors Market Share by Application in 2018
Table North America BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table North America BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table North America BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure United States BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Canada BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Mexico BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Europe BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Europe BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Europe BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table Europe BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Europe BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Application in 2018
Table Europe BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Europe BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Europe BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Europe BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Germany BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure France BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure UK BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Italy BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Russia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Asia Pacific BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Sales by Regions (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Market Share by Type in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Market Share by Application in 2018
Table Asia Pacific BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Sales Market Share by Regions in 2018
Table Asia Pacific BRAF Kinase Inhibitors Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific BRAF Kinase Inhibitors Revenue Market Share by Regions in 2018
Figure China BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure China BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Japan BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Korea BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure India BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure India BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Australia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Indonesia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Malaysia BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Philippines BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Thailand BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Vietnam BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Central & South America BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America BRAF Kinase Inhibitors Sales by Company (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Company (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Sales Market Share by Company in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Market Share by Type in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Market Share by Application in 2018
Table Central & South America BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Central & South America BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Central & South America BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Central & South America BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Brazil BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Growth Rate 2014-2019 (K Liter)
Figure Middle East and Africa BRAF Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Type (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Type (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Type in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Application (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Application (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Application in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Sales by Countries (2014-2019) (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa BRAF Kinase Inhibitors Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure GCC Countries BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure GCC Countries BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure Egypt BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure Egypt BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Figure South Africa BRAF Kinase Inhibitors Sales Growth Rate (2014-2019) (K Liter)
Figure South Africa BRAF Kinase Inhibitors Revenue Growth Rate (2014-2019) (K Liter)
Table Array BioPharma Inc. Company Details
Table Array BioPharma Inc. Description and Business Overview
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Array BioPharma Inc. BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Array BioPharma Inc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Description and Business Overview
Table Bayer AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Bayer AG BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Bayer AG BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Bayer AG Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Description and Business Overview
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (Million US$), Price (USD/Liter) and Gross Margin (2014-2019)
Table Novartis AG BRAF Kinase Inhibitors Sales Growth Rate (2014-2019)
Table Novartis AG BRAF Kinase Inhibitors Sales Market Share in Global Market
Table Novartis AG Recent Development
Figure BRAF Kinase Inhibitors Value Chain
Table BRAF Kinase Inhibitors Distributors List
Table BRAF Kinase Inhibitors Customers List
Table Global BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter) & (Million US$)
Figure Global BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Revenue Forecast 2019-2025 (Million US$)
Table Global BRAF Kinase Inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Type 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Type 2019-2025
Table Global BRAF Kinase Inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Application 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Application 2019-2025
Table Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Figure Global BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Table North America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table North America BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table North America BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure United States BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Canada BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Mexico BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Europe BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Europe BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Germany BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure France BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure UK BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Italy BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Russia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Asia Pacific BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure China BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Japan BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Korea BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure India BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Australia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Indonesia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Thailand BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Malaysia BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Philippines BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Vietnam BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Forecast by Countries 2019-2025 (K Liter)
Table Central & South America BRAF Kinase Inhibitors Sales Market Share Forecast by Countries 2019-2025
Table Central & South America BRAF Kinase Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America BRAF Kinase Inhibitors Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Forecast by Regions 2019-2025 (K Liter)
Table Middle East and Africa BRAF Kinase Inhibitors Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa BRAF Kinase Inhibitors Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure GCC Countries BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure Egypt BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Figure South Africa BRAF Kinase Inhibitors Sales Forecast 2019-2025 (K Liter)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Array BioPharma Inc.、Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のBRAFキナーゼ阻害剤産業:成長傾向・競合分析(Global BRAF Kinase Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。